Pancreatic ductal adenocarcinoma (PDAC) is known for its aggressive biology and lethality. Superior to conventional biomedical research models, the focus of this study is on the development and use of well-established patient-derived organoids (PDO)- and xenografts (PDX), mimicking the tumor as it is present in a human body. The models are extensively analysed using advanced spatial-omics analysis to investigate the ability to recapitulate two main molecular subtypes of PDAC.
|Publication status||Unpublished - 2021|
|Event||European Pancreatic Club - Verona - online event|
Duration: 9 Jun 2021 → 11 Jun 2021
|Conference||European Pancreatic Club|
|Period||9/06/21 → 11/06/21|